RXDX - Prometheus Biosciences GAAP EPS of -$0.86 beats by $0.06 revenue of $1.26M beats by $0.8M
- Prometheus Biosciences press release ( NASDAQ: RXDX ): Q2 GAAP EPS of -$0.86 beats by $0.06 .
- Revenue of $1.26M (+320.0% Y/Y) beats by $0.8M .
For further details see:
Prometheus Biosciences GAAP EPS of -$0.86 beats by $0.06, revenue of $1.26M beats by $0.8M